155 related articles for article (PubMed ID: 35843311)
21. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
22. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
[TBL] [Abstract][Full Text] [Related]
23. LATS1 Regulates Mixed-Lineage Kinase 3 (MLK3) Subcellular Localization and MLK3-Mediated Invasion in Ovarian Epithelial Cells.
Kasturirangan S; Mehdi B; Chadee DN
Mol Cell Biol; 2021 Jun; 41(7):e0007821. PubMed ID: 33875576
[TBL] [Abstract][Full Text] [Related]
24. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
26. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1.
Casagrande F; Darbon JM
Biochem Pharmacol; 2001 May; 61(10):1205-15. PubMed ID: 11322924
[TBL] [Abstract][Full Text] [Related]
27. Cyclin B/CDK1 and Cyclin A/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division.
Clemm von Hohenberg K; Müller S; Schleich S; Meister M; Bohlen J; Hofmann TG; Teleman AA
Nat Commun; 2022 Feb; 13(1):668. PubMed ID: 35115540
[TBL] [Abstract][Full Text] [Related]
28. Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.
Blessing NA; Kasturirangan S; Zink EM; Schroyer AL; Chadee DN
Cell Signal; 2017 Nov; 39():66-73. PubMed ID: 28757353
[TBL] [Abstract][Full Text] [Related]
29. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
O'Connor PM; Ferris DK; Pagano M; Draetta G; Pines J; Hunter T; Longo DL; Kohn KW
J Biol Chem; 1993 Apr; 268(11):8298-308. PubMed ID: 8463339
[TBL] [Abstract][Full Text] [Related]
30. Raptor is phosphorylated by cdc2 during mitosis.
Gwinn DM; Asara JM; Shaw RJ
PLoS One; 2010 Feb; 5(2):e9197. PubMed ID: 20169205
[TBL] [Abstract][Full Text] [Related]
31. Differential cyclin-dependent kinase expression and activation in human colon cancer.
Salh B; Bergman D; Marotta A; Pelech SL
Anticancer Res; 1999; 19(1B):741-8. PubMed ID: 10216486
[TBL] [Abstract][Full Text] [Related]
32. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.
Moore NL; Weigel NL
Int J Biochem Cell Biol; 2011 Aug; 43(8):1157-67. PubMed ID: 21550420
[TBL] [Abstract][Full Text] [Related]
33. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C
J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430
[TBL] [Abstract][Full Text] [Related]
34. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
35. Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells.
Van Horn RD; Chu S; Fan L; Yin T; Du J; Beckmann R; Mader M; Zhu G; Toth J; Blanchard K; Ye XS
J Biol Chem; 2010 Jul; 285(28):21849-57. PubMed ID: 20444701
[TBL] [Abstract][Full Text] [Related]
36. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells.
Hong HY; Kim BC
Biochem Biophys Res Commun; 2007 Oct; 362(2):307-12. PubMed ID: 17707342
[TBL] [Abstract][Full Text] [Related]
37. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
38. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
Chow JP; Siu WY; Ho HT; Ma KH; Ho CC; Poon RY
J Biol Chem; 2003 Oct; 278(42):40815-28. PubMed ID: 12912980
[TBL] [Abstract][Full Text] [Related]
39. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.
Zhan Y; Abi Saab WF; Modi N; Stewart AM; Liu J; Chadee DN
Exp Cell Res; 2012 Aug; 318(14):1641-8. PubMed ID: 22652451
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]